Log in to search using one of your social media accounts:

 

Structural description of the marketed form of valsartan: A crystalline mesophase characterized by nanocrystals and conformational disorder

Publication date: 30 June 2017 Source:International Journal of Pharmaceutics, Volume 526, Issues 1–2 Author(s): Yannick Guinet, Laurent Paccou, Florence Danède, Patrick Derollez, Alain Hédoux Valsartan is an antihypertensive drug, recognized to be marketed in an amorphous state, different from that obtained by quenching the liquid state below T g. This is an unusual and very original situation, given that the amorphous state is unstable. Low-wavenumber Raman spectroscopy and X-ray diffraction investigations were carried out on the various solid-state forms of valsartan. It was found that the marketed form is not amorphous and can be described in terms of mesophase in which the long-range order of the stable crystal is limited on the lengthscale of tens nanometers, inducing a melting temperature lower than that of the stable crystalline state, inherent to the crystallite size. This unusual physical state of a marketed drug was correlated to the relative population of cis–trans conformers, preventing the development of the hydrogen-bond network distinctive of the long-range order in the crystalline state. Graphical abstract
Source: International Journal of Pharmaceutics - Category: Drugs & Pharmacology Source Type: research

Related Links:

Authors: Bernet W PMID: 29223448 [PubMed - in process]
Source: L Encephale - Category: Psychiatry Tags: Encephale Source Type: research
Source: Contraception - Category: OBGYN Source Type: research
Source: Contraception - Category: OBGYN Source Type: research
Maria Esposito, Antonietta Messina, Vincenzo Monda, Ilaria Bitetti, Filomena Salerno, Francesco Precenzano, Simone Pisano, Tiziana Salvati, Antonella Gritti, Rosa Marotta, Serena Marianna Lavano, Francesco Lavano, Agata Maltese, Lucia Parisi, Margherita Salerno, Gabriele Tripi, Beatrice Gallai, Michele Roccella, Domenico Bove, Maria Ruberto, Roberto Toraldo, Giovanni Messina, Marco Carotenuto
Source: Frontiers in Neurology - Category: Neurology Source Type: research
Ricardo Matias, Vitor Paix ão, Raquel Bouça, Joaquim J. Ferreira
Source: Frontiers in Neurology - Category: Neurology Source Type: research
Wei Liu, Shuo Lu, Yibo Feng, Zhiyong Zhang, Peng Liu, Zunjing Liu
Source: Frontiers in Neurology - Category: Neurology Source Type: research
Roland Fritsch, Shaun P. Collin, Nico K. Michiels
Source: Frontiers in Neuroanatomy - Category: Neurology Source Type: research
Lisa Basler, Stephan Gerdes, David P. Wolfer, Lutz Slomianka
Source: Frontiers in Neuroanatomy - Category: Neurology Source Type: research
Daesung Kang, Mingzhou Ding, Irina Topchiy, Bernat Kocsis
Source: Frontiers in Neuroanatomy - Category: Neurology Source Type: research
Sergey A. Shuvaev, Alexander A. Lazutkin, Alexander V. Kedrov, Konstantin V. Anokhin, Grigori N. Enikolopov, Alexei A. Koulakov
Source: Frontiers in Neuroanatomy - Category: Neurology Source Type: research
More News: Diovan | Drugs & Pharmacology | Nanotechnology